Abstract
Nowadays, limus-eluting stents dominate the world of drug-eluting stents (DES) and proved to be superior to paclitaxel-eluting stents in terms of efficacy and safety [1].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Windecker S, Stortecky S, Stefanini GG, da Costa BR, Rutjes AW, Di Nisio M, Silletta MG, Maione A, Alfonso F, Clemmensen PM, Collet J-P, Cremer J, Falk V, Filippatos G, Hamm C, Head S, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann F-J, Richter D, Schauerte P, Sousa Uva M, Taggart DP, Torracca L, Valgimigli M, et al. Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis. BMJ. 2014;348:g3859.
Wöhrle J. Drug-coated balloons for coronary and peripheral interventional procedures. Curr Cardiol Rep. 2012;14:635–41.
Scheller B, Speck U, Abramjuk C, Bernhardt U, Böhm M, Nickenig G. Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation. 2004;110:810–4.
Cortese B, Bertoletti A. Paclitaxel coated balloons for coronary artery interventions: a comprehensive review of preclinical and clinical data. Int J Cardiol. 2012;161:4–12.
Kaule S, Minrath I, Stein F, Kragl U, Schmidt W, Schmitz K-P, Sternberg K, Petersen S. Correlating coating characteristics with the performance of drug-coated balloons – a comparative in vitro investigation of own established hydrogel- and ionic liquid-based coating matrices. PLoS One. 2015;10:e0116080.
Windecker S, Kolh P, Alfonso F, Collet J-P, Cremer J, Falk V, Filippatos G, Hamm C, Head SJ, Juni P, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann F-J, Richter DJ, Schauerte P, Sousa Uva M, Stefanini GG, Taggart DP, Torracca L, Valgimigli M, Wijns W, Witkowski A. 2014 ESC/EACTS guidelines on myocardial revascularization. EuroIntervention. 2015;10:1024–94.
Wöhrle J, Zadura M, Möbius-Winkler S, Leschke M, Opitz C, Ahmed W, Barragan P, Simon J-P, Cassel G, Scheller B. SeQuent Please World Wide Registry: clinical results of SeQuent please paclitaxel-coated balloon angioplasty in a large-scale, prospective registry study. J Am Coll Cardiol. 2012;60:1733–8.
Lemos PA, Farooq V, Takimura CK, Gutierrez PS, Virmani R, Kolodgie F, Christians U, Kharlamov A, Doshi M, Sojitra P, van Beusekom HMM, Serruys PW. Emerging technologies: polymer-free phospholipid encapsulated sirolimus nanocarriers for the controlled release of drug from a stent-plus-balloon or a stand-alone balloon catheter. EuroIntervention. 2013;9:148–56.
Parikh KH, Shetty R, Dani S, Bhatt P, Doshi M, Sojitra P. Real-world safety and outcome measures of novel sirolimus coated balloon catheter. J Am Coll Cardiol. 2016;67:225.
Clever YP, Peters D, Calisse J, Bettink S, Berg M-C, Sperling C, Stoever M, Cremers B, Kelsch B, Böhm M, Speck U, Scheller B. Novel sirolimus-coated balloon catheter: in vivo evaluation in a porcine coronary model. Circ Cardiovasc Interv. 2016;e003543:9.
Verheye S, Vrolix M, Kumsars I, Erglis A, Sondore D, Agostoni P, Cornelis K, Janssens L, Maeng M, Slagboom T, Amoroso G, Jensen LO, Granada JF, Stella P. The SABRE trial (sirolimus angioplasty balloon for coronary in-stent restenosis): angiographic results and 1-year clinical outcomes. JACC Cardiovasc Interv. 2017;10:2029–37.
Cortese B, Dani S, Parikh K, Kumar P. TCT-643 safety and efficacy of Sirolimus coated balloon for the treatment of coronary lesions in small vessels: a subgroup analysis from the Nanolute registry. J Am Coll Cardiol. 2017;70:B283.
Dani S, Parikh K, Kumar P. TCT-210 Sirolimus coated balloon in the treatment of coronary artery disease in diabetic patients: results from Nanolute registry. J Am Coll Cardiol. 2017;70:B88–9.
Parikh K, Dani S, Kumar P. TCT-641 Sirolimus coated balloon for the treatment of coronary in-stent restenosis: insights from Nanolute registry. J Am Coll Cardiol. 2017;70:B283.
Waksman R, Serra A, Loh JP, Malik FT-N, Torguson R, Stahnke S, Strandmann von RP, Rodriguez AE. Drug-coated balloons for de novo coronary lesions: results from the Valentines II trial. EuroIntervention. 2013;9:613–9.
Cortese B, Di Palma G, Latini RA, Elwany M, Orrego PS, Seregni RG. Immediate and short-term performance of a novel sirolimus-coated balloon during complex percutaneous coronary interventions. The FAtebenefratelli SIrolimus COated-balloon (FASICO) registry. Cardiovasc Revasc Med. 2017;18(7):487–91.
Cortese B, Sgueglia GA, Berti S, Biondi-Zoccai G, Colombo A, Limbruno U, Bedogni F, Cremonesi A, Italian Society of Interventional Cardiology (SICI-GISE). SICI-GISE position paper on drug-coated balloon use in the coronary district. G Ital Cardiol. 2013;14(10):681–9.
Cortese B, Berti S, Biondi-Zoccai G, Colombo A, Limbruno U, Bedogni F, Cremonesi A, Silva PL, Sgueglia GA, Italian Society of Interventional Cardiology. Drug-coated balloon treatment of coronary artery disease: a position paper of the Italian Society of Interventional Cardiology. Catheter Cardiovasc Interv. 2014;83(3):427–35.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Di Palma, G., Cortese, B. (2019). Sirolimus-Coated Balloon: Insights on a New Technology for Coronary Use. In: Cortese, B. (eds) Drug-Coated Balloons . Springer, Cham. https://doi.org/10.1007/978-3-319-92600-1_14
Download citation
DOI: https://doi.org/10.1007/978-3-319-92600-1_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-92599-8
Online ISBN: 978-3-319-92600-1
eBook Packages: MedicineMedicine (R0)